Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference
September 06 2018 - 3:00PM
Business Wire
Bristol-Myers Squibb Company (NYSE:BMY) will take part in the
Morgan Stanley 2018 Global Health Care Conference on Thursday,
September 13, 2018, in New York. Giovanni Caforio, M.D., chairman
and chief executive officer will make formal remarks about the
company and answer questions at 11:10 a.m. EDT.
Investors and the general public are invited to listen to a live
webcast of the session at http://investor.bms.com. Materials
related to the presentation will be available at the same website
at the start of the live webcast. An archived edition of the
session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter,
YouTube and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180906005709/en/
Bristol-Myers SquibbMedia:Lisa McCormick Lavery,
609-252-7602lisa.mccormicklavery@bms.comorInvestors:Tim
Power, 609-252-7509timothy.power@bms.comorBill Szablewski,
609-252-5894william.szablewski@bms.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2023 to Apr 2024
